Topical Formulation CDMO Gains Momentum as Demand for Advanced Drug Delivery Surges
The global pharmaceutical outsourcing landscape is witnessing rapid transformation, with Topical Formulation CDMO services emerging as a key growth engine. As demand for dermatological and localized therapies continues to rise, Topical Formulation CDMO providers are playing an increasingly strategic role in accelerating drug development and commercialization.
2026-04-09
Date: 28–30 April 2026 Venue: COEX Convention & Exhibition Center, Seoul, South Korea
2026-04-02
Anglonordic Life Science Conference 2026
Date: 23 April 2026 Venue: County Hall, London, UK
2026-04-02
Date: 21–23 April 2026 Venue: Tokyo Big Sight (Tokyo International Exhibition Center), Tokyo, Japan Jiuzhou Booth: 3C-04
2026-04-02
American Association for Cancer Research (AACR)
Date: 17–21 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA
2026-04-02
Date: 21–22 April 2026 Venue: Kongresshalle am Zoo, Leipzig, Germany
2026-04-02
42nd SCI Process Development Symposium 2026
Date: 15–17 April 2026 Venue: Churchill College, University of Cambridge, Cambridge, UK
2026-04-02
Date: 13–16 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA
2026-04-02
Date: 14–16 April 2026 Venue: Paris Expo Porte de Versailles, Paris, France
2026-04-02
Fluorine Chemistry CDMO Accelerates Innovation in Global Pharmaceutical Development
The rapid evolution of the pharmaceutical industry is driving increasing demand for specialized services such as Fluorine Chemistry, a niche yet critical segment supporting the development of advanced drug molecules.
2026-04-02
Drug Development Services Enable Faster Translation from Research to Application
In the future, drug development is moving towards collaboration and platformization. Drug Development Services will play a more robust supporting role in the innovative drug ecosystem, creating greater long-term value for companies.
2026-03-23
2026-05-14
2026-04-23
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services（API）
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com
